Clinicopathologic characteristics and survival outcomes of gastroenteropancreatic neuroendocrine neoplasms in Peru: A 15-year retrospective cohort study
PLOS One · 05.11.2026 · 21 (11) · e0361867
DOI: 10.1371/journal.pone.0361867 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift PLOS One, online erschienen am 05.11.2026. Verfasst von Wagner Eduardo Cruz-Diaz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors, Intestinal Neoplasms, Stomach Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) has increased globally; however, data from Latin America remain scarce. This study aimed to describe the sociodemographic and clinicopathologic characteristics, treatment modalities, survival outcomes, and prognostic factors of GEP-NENs in a 15-year single-center cohort at a national referral cancer center in Lima, Peru. Materials and methods We conducted a retrospective, hospital-based cohort study. Patients diagnosed with GEP-NENs at the Instituto Nacional de Enfermedades Neoplásicas (INEN) were included from 2009 to 2024, and tumors were classified according to the 2019 WHO Classification of GEP-NENs. Overall survival (OS) was estimated using Kaplan-Meier curves and compared using the log-rank test. Prognostic factors were identified through Cox proportional hazards models.
Results
Three hundred sixty-eight patients were included. The median age at diagnosis was 57 years, with a female predominance (56.2%). Most patients presented with an ECOG performance status of 0–1 (96.5%), and among patients with available disease-extent information, 64.7% had non-metastatic disease. The majority of tumors were well-differentiated (neuroendocrine tumors [NETs]) (84.2%), while 15.8% were poorly differentiated (neuroendocrine carcinomas [NECs]). The most common primary tumor sites included the rectum (39.1%), stomach (19.8%), and pancreas (18.8%). With a median follow-up of 61.9 months, the 5-year OS rate was 52%. NETs exhibited longer OS than NECs, with 5-year OS rates of 65% and 8%, respectively (log-rank p < 0.001). In the multivariable analysis, metastatic disease (aHR = 2.61, 95% CI: 1.63–4.20; p < 0.001) and poorly differentiated histology (aHR: 4.36, 95% CI: 2.59–7.31; p < 0.001) were independently associated with worse overall survival, whereas surgery (aHR: 0.25, 95% CI: 0.15–0.41; p < 0.001) and systemic treatment (aHR: 0.53, 95% CI: 0.31–0.92; p = 0.024) were associated with improved overall survival.
Conclusion
Our findings demonstrate that GEP-NENs represent a highly heterogeneous group of neoplasms with substantial variability in clinicopathological characteristics and survival outcomes. Most patients in our cohort had well-differentiated NETs and favorable long-term survival. These findings support the need for comprehensive national registries and multicenter collaborative studies to validate our results and better characterize GEP-NENs in underrepresented Latin American populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.
- Escuela de Medicina Humana, Universidad Privada San Juan Bautista, Lima, Peru.
- Universidad Científica del Sur, Lima, Peru.
ORCID-Profile: Gabriel De la Cruz Ku
Zitieren
APA
Cruz-Diaz, W. E., Haro-Varas, J., Enriquez-Vera, D., De la Cruz Ku, G., Torres-Valdivia, N., Paitán Amaro, V., Saavedra, A., Merubia, A., Leonardo Carbajal, A., Macetas Núñez, J., Veramendi Cabana, E., Pacheco Román, C., Calderón Anticona, M., Vidaurre Rojas, T., & Castro-Oliden, V. (2026). Clinicopathologic characteristics and survival outcomes of gastroenteropancreatic neuroendocrine neoplasms in Peru: A 15-year retrospective cohort study. PLOS One, 21(11), e0361867. https://doi.org/10.1371/journal.pone.0361867
Vancouver
Cruz-Diaz WE, Haro-Varas J, Enriquez-Vera D, De la Cruz Ku G, Torres-Valdivia N, Paitán Amaro V, et al. Clinicopathologic characteristics and survival outcomes of gastroenteropancreatic neuroendocrine neoplasms in Peru: A 15-year retrospective cohort study. PLOS One. 2026;21(11):e0361867. doi:10.1371/journal.pone.0361867
BibTeX
@article{CruzDiaz2026,
author = {Cruz-Diaz, Wagner Eduardo and Haro-Varas, Juan and Enriquez-Vera, Daniel and De la Cruz Ku, Gabriel and Torres-Valdivia, Nattaly and Paitán Amaro, Víctor and Saavedra, Alexandra and Merubia, Alejandro and Leonardo Carbajal, Angela and Macetas Núñez, Jackeline and Veramendi Cabana, Eder and Pacheco Román, Cristian and Calderón Anticona, Mónica and Vidaurre Rojas, Tatiana and Castro-Oliden, Victor},
title = {Clinicopathologic characteristics and survival outcomes of gastroenteropancreatic neuroendocrine neoplasms in Peru: A 15-year retrospective cohort study},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {11},
pages = {e0361867},
doi = {10.1371/journal.pone.0361867}
}
EUVIMED